With this in mind, we examined the effects of the selective IKKβ inhibitors IKKβIII or IKKβV on osteoblast proliferation and differentiation in the presence of conditioned medium from human MDA-231 and mouse breast cancer cells. This evidence concerns the gene IKBKB and breast cancer.